Arrowgrass Capital Partners (US)’s Bristol-Myers Squibb BMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-100,000	Closed	-$5.07M	–	78
2019 Q3	$5.07M	Hold	100,000	–	–	0.85%	76
2019 Q2	$4.54M	Sell	100,000 -140,000	-58%	-$6.52M	0.15%	200
2019 Q1	$11.4M	Buy	+240,000	New	+$12M	0.58%	93
2018 Q1	–	Sell	-148,900	Closed	-$9.13M	–	198
2017 Q4	$9.13M	Buy	148,900 +147,099	+8,168%	+$9.2M	0.22%	237
2017 Q3	$11.5M	Sell	1,801 -993	-36%	-$58K	0.19%	258
2017 Q2	$15.6M	Buy	2,794 +790	+39%	+$43K	0.26%	224
2017 Q1	$10.9M	Buy	2,004 +1,848	+1,185%	+$101K	0.26%	229
2016 Q4	$912K	Buy	156 +88	+129%	+$4.81K	0.02%	433
2016 Q3	$367K	Hold	68	–	–	0.01%	409
2016 Q2	$500K	Buy	68 +8	+13%	+$565	0.01%	376
2016 Q1	$383K	Sell	60 -300	-83%	-$18.9K	0.01%	356
2015 Q4	$2.48M	Hold	360	–	–	0.05%	226
2015 Q3	$2.13M	Hold	360	–	–	0.07%	253
2015 Q2	$2.4M	Buy	360 +63	+21%	+$4.15K	0.07%	314
2015 Q1	$1.92M	Sell	297 -983,803	-100%	-$61.6M	0.06%	258
2014 Q4	$58.1M	Buy	984,100 +399,300	+68%	+$22.5M	1.6%	18
2014 Q3	$29.9M	Buy	+584,800	New	+$29.2M	1.08%	26
2013 Q4	–	Sell	-100,000	Closed	-$4.63M	–	161
2013 Q3	$4.63M	Buy	+100,000	New	+$4.39M	0.21%	104